WTO’s COVID-19 Waiver Negotiations
The waiver parameters of the current proposal are different from that originally proposed by India and South Africa in October 2020. Whereas the original proposal included waiver of patent protection related to prevention, containment, or treatment of COVID-19, the current proposal is limited to “production and supply of COVID-19 vaccines.” The current proposal makes clear that the use of the eligible subject matter can be authorized by “any instrument available” under the laws of the member country, such as executive orders, emergency decrees, and judicial or administrative orders, without the need for legislative acts. Furthermore, the current proposal makes clear that the eligible member country need not make efforts to obtain permission from the patent owner prior to authorization of the waiver. The current proposal also makes clear the eligible member countries “shall undertake all reasonable efforts to prevent re-exportation of the COVID-10 vaccine” imported in accordance with the waiver.
Several provisions in the current proposal, however, show the need for further resolution on at least three points. The first pertains to which member countries are eligible to authorize a waiver. The current proposal limits the right to waive patent protection to “developing country Members,” who are encouraged to opt out if they have the capacity to export, or, in the alternative, excludes “developing country Members who exported more than 10 percent of world exports of COVID-19 vaccine doses in 2021.”2 The exclusion of exporters of more than 10% seems to be directed to China, which is designated a developing country but currently exports 32% of world exports of COVID-19 vaccines.3 Developing countries that would be encouraged to opt out, however, could also include countries like India and South Africa which also export COVID-19 vaccines.4
The second provision in the current proposal pertaining to the scope of authorization by an eligible member is designated as “under further consideration to whether to keep or delete.” Specifically, the provision states that a single authorization for the use of multiple patents can be used and may be updated to add additional patents. The provision further states that the Member can be assisted by WIPO’s patent landscaping work5 in order to determine relevant patents, including those related to “underlying technologies on COVID-19 vaccines.” Thus, it appears that the WTO members will determine whether a developing country member can authorize a blanket waiver of all the listed vaccine patents on the WIPO landscape report. The list currently includes 417 patents.6
A third provision designates a period during which an eligible member country may authorize the waiver as either 3 or 5 from the date of any final decision. Given this and the remaining aspects of the proposal requiring negotiation and given that the Director-General makes clear in her cover letter that none of the participating members of the informal group that produced the proposal is bound by the terms, the proposal will still be subject to much debate and modification.
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.